- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04974476
Onsite vs. Virtual Group Fitness in Overweight/Obese Women
November 9, 2021 updated by: Arlette Perry, University of Miami
A Comparison of Onsite vs. Virtual Fitness Program on Anthropometric Measures, Aerobic Fitness, and Vascular Markers of Cardiac Risk Markers in Overweight/Obese Premenopausal Women
The purpose of this study is to compare an onsite to virtual whole-body high intensity interval training (HIIT) program on anthropometric variables, aerobic fitness measures, and vascular markers of cardiac risk in a single study of overweight and obese women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Coral Gables, Florida, United States, 33134
- University of Miami
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 44 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Premenopausal adult females over the age of 18 and under the age of 45 with a BMI greater than or equal to 25 and a waist circumference greater than or equal to 35 inches.
- No medical contraindications to participation in an exercise program including major medical illnesses (i.e. cardiovascular disease, stroke, cancer, etc.)
- Ability to provide informed consent
- Willingness and ability to participate in an interval training in-person group fitness exercise program 3x/week for 12 weeks
Exclusion Criteria:
- Adults unable to consent or mini-mental score less than 18.
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Post-menopausal women
- Do not speak English
- Prisoners
- Subjects on medicines (serum glucose, insulin, weight loss medicines, beta-blockers) and having any medical pre-conditions that would interfere with one's capacity to exercise.
- Answer "Yes" to any of the questions on the Pre-Activity Screening Questionnaire (PASQ)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: In-person exercise training group
participants in this group will receive in person exercise HIIT training 3 days a week for 12 weeks
|
The HIIT total session duration will be approximately 30 minutes and will be composed of 10 sets of 60 seconds of high-intensity exercises, >80% of maximum heart rate (MHR), interspersed with a recovery period of 60 seconds of low-intensity exercise at 60% of MHR.
|
|
Experimental: Virtual exercise training group
participants in this group will receive virtual exercise HIIT training 3 days a week for 12 weeks
|
The HIIT total session duration will be approximately 30 minutes and will be composed of 10 sets of 60 seconds of high-intensity exercises, >80% of maximum heart rate (MHR), interspersed with a recovery period of 60 seconds of low-intensity exercise at 60% of MHR.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pulse Wave Velocity (PWV)
Time Frame: Up to 12 weeks
|
vascular marker of cardiac risk will be reported as PWV (m/s) as measured using SphygmoCor
|
Up to 12 weeks
|
|
Pulse Wave Analysis Augmentation Index (AIx)
Time Frame: Up to 12 weeks
|
vascular marker of cardiac risk will be reported as AIx (%) as measured using SphygmoCor
|
Up to 12 weeks
|
|
Pulse Wave Analysis Mean Arterial Pressure (MAP)
Time Frame: Up to 12 weeks
|
vascular marker of cardiac risk will be reported as MAP (mmHg) as measured using SphygmoCor
|
Up to 12 weeks
|
|
Visceral Adipose Tissue (VAT) content
Time Frame: Up to 12 weeks
|
Anthropometric measure will be reported as VAT content as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer
|
Up to 12 weeks
|
|
Total Adiposity
Time Frame: Up to 12 weeks
|
Anthropometric measure will be reported as Total Adiposity as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer
|
Up to 12 weeks
|
|
Aerobic Fitness
Time Frame: Up to 12 weeks
|
Aerobic Fitness level as measured by the 20 meter shuttle run
|
Up to 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Arlette C Perry, University of Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 24, 2021
Primary Completion (Actual)
November 8, 2021
Study Completion (Actual)
November 8, 2021
Study Registration Dates
First Submitted
July 14, 2021
First Submitted That Met QC Criteria
July 14, 2021
First Posted (Actual)
July 23, 2021
Study Record Updates
Last Update Posted (Actual)
November 10, 2021
Last Update Submitted That Met QC Criteria
November 9, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20210038
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
National Taiwan University HospitalCompleted
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
Clinical Trials on HIIT Exercise Training
-
Universidade Federal do Rio de JaneiroUnknown
-
Universidad de Los LagosUniversidad de La FronteraCompletedHyperglycemia | Exercise Training | Type2 Diabetes Mellitus | Heart RateChile
-
Hasselt UniversityJessa HospitalCompletedType2 Diabetes | Diabetic CardiomyopathiesBelgium
-
Stanford UniversityCompleted
-
University of California, San FranciscoTerminatedPostoperative Delirium and Delayed Functional RecoveryUnited States
-
Lund UniversityThe Swedish Research Council; Region Skane; Halmstad UniversityActive, not recruiting
-
Université du Québec a MontréalMcGill University; Université de MontréalCompleted
-
Beijing Sport UniversityCompletedVascular DiseasesChina
-
Cardiovascular and Pulmonary Rehabilitation Center...Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaboratorsCompleted
-
University of Dublin, Trinity CollegeCompletedLung Neoplasms | Colorectal NeoplasmsIreland